PharmacologyChurchill Livingstone, 2001 - 839 pagine Adapted for the U.S., this New Edition of PHARMACOLOGY, a popular UK text, describes what drugs do and emphasizes the mechanisms by which they act. The U.S. edition is revised and updated to reflect the substantial differences in drug names, FDA approvals, terminology, and guidelines for use. It also boasts new and revised chapters to ensure that students are up to date on the very latest information. Each chapter begins with a summary of information essential to the chapter and key points are highlighted within the text to alert students to crucial concepts. Spanish version also available, ISBN: 84-8174-492-1 |
Dall'interno del libro
Risultati 1-3 di 87
Pagina 196
... tissue from babies with ideopathic hypertrophic pyloric stenosis . ** Clinical uses of NO donors and NO as a therapeutic gas , and of inhibition of the L - arginine / NO system are summarized in the clinical box below . 100 -8 -6 -7 -5 ...
... tissue from babies with ideopathic hypertrophic pyloric stenosis . ** Clinical uses of NO donors and NO as a therapeutic gas , and of inhibition of the L - arginine / NO system are summarized in the clinical box below . 100 -8 -6 -7 -5 ...
Pagina 210
... tissue as well as local proliferation of cells and connective tissue . The principal cell types found in areas of chronic inflammation are mononuclear cells and abnormal cells derived from macrophages . In areas of healing and chronic ...
... tissue as well as local proliferation of cells and connective tissue . The principal cell types found in areas of chronic inflammation are mononuclear cells and abnormal cells derived from macrophages . In areas of healing and chronic ...
Pagina 312
... tissue factor " , which is the cellular receptor and cofactor for factor VII , which undergoes an active site transition on binding to tissue factor in the presence of Ca2 + , enhancing its activity and resulting in rapid autocatalytic ...
... tissue factor " , which is the cellular receptor and cofactor for factor VII , which undergoes an active site transition on binding to tissue factor in the presence of Ca2 + , enhancing its activity and resulting in rapid autocatalytic ...
Sommario
general principles | 11 |
molecular aspects | 19 |
Method and measurement in pharmacology | 47 |
Copyright | |
45 sezioni non visualizzate
Altre edizioni - Visualizza tutto
Parole e frasi comuni
5-HT receptors absorption acetylcholine action potential activity adrenoceptors agents agonists amino acids anesthetics antidepressant antipsychotic asthma benzodiazepines binding block blood bradykinin brain Ca2+ cancer cardiac cause cells chemical cholinergic clinical compounds cytokines decrease depolarization depression disease diuretics dopamine dose drugs enzyme estrogens ethanol excretion factors function GABA gastrointestinal gene glucocorticoids glucose glutamate histamine hormone important inactivation increase inflammatory inhibition inhibitors injection insulin interaction intracellular intravenous kinase leptin liver mainly mechanism of action mediators membrane metabolism metabolites molecular molecules morphine muscarinic nerve terminals neurons nicotine norepinephrine normal occurs opioid orally oxide pathway patients peptide peripheral Pharmacokinetic Pharmacol pharmacological physiological pituitary plasma concentration platelet presynaptic produce prostaglandins protein reactions receptor antagonists reduced release renal response result role secretion side-effects smooth muscle sodium stimulation substance sympathetic synaptic synthesis therapeutic therapy tissue toxicity transmission transmitter treatment tubule unwanted effects uptake vascular vasoconstriction vitamin